Alessio Branchini Shares His Latest Work on Albumin-Fused Factor IX Variants and Thanks The Whole Team
Alessio Branchini, Associate Professor of Molecular Biology at University of Ferrara, shared on LinkedIn:
”Very proud to announce that our paper is published!
Great and hard, but exciting, work on the characterization and biodistribution of engineered albumin-fused factor IX variants with tailored biinding to extravascular collagen.
Wonderful collaborations involving our group at the University of Ferrara, the team at the University of Oslo and the San Raffaele Hospital.
From the University of Ferrara side, excellent work by Maria Francesca Testa, Rebecca Tarantino and Mascia Benedusi.
Very thankful to Jan Terje Andersen, Kristin Hovden Aaen and Jeannette Nilsen (University of Oslo for the wonderful and ongoing collaboration (10 years!), to Alessio Cantore and Cesare Canepari (Ospedale San Raffaele) for their extremely valuable contribution, as well as to all collaborators.
Together we made this story possible.
Of course, a particular thank you to my (and our) mentors Francesco Bernardi and Mirko Pinotti at the University of Ferrara.
Last but not least, I am really grateful to the Access to Insight Basic Research Grant program by Novo Nordisk.
Press releases on Eurekalert and on the news site of University of Ferrara.”
Read the full article in Nature Communications.
Article: Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties
Authors: Kristin Hovden Aaen, Maria Francesca Testa, Jeannette Nilsen, Rebecca Tarantino, Cesare Canepari, Mascia Benedusi, Sopisa Benjakul, Mari Nyquist-Andersen, Marie Leangen Herigstad, Alessio Cantore, Giuseppe Valacchi, Inger Sandlie, Francesco Bernardi, Mirko Pinotti, Alessio Branchini, Jan Terje Andersen
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 29, 2026, 17:05What If Factor XI inhibition Could Reshape the Future of Anticoagulation – ISTH
-
Aug 29, 2026, 16:44Nipocalimab for Warm Autoimmune Hemolytic Anemia: What the FDA Approval Means
-
Aug 29, 2026, 16:17The Future of Bleeding Disorder Research is Getting Bigger – Global Hemophilia Report
-
Aug 29, 2026, 16:03Marco De Giovanni: The Platelet – Serotonin Link Behind Severe COVID-19
-
Aug 29, 2026, 16:01FDA Approves Imaavy for wAIHA – Thalassaemia International Federation
-
Aug 29, 2026, 16:00Dianne E. van der Wal: Advancing Platelet Research at ISTH 2026 in Paris
-
Aug 29, 2026, 15:55Cory Dugan: Iron Deficiency and Anemia Across the Female Life
-
Aug 29, 2026, 15:53Melina Rodriguez: FDA Approves Imaavy as First Treatment for Warm AIHA
-
Aug 29, 2026, 15:50Karen T․: Seeking a Patient Liaison to Support the Bleeding Disorders Community